Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 27
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Core Laboratories Inc
CLB
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$10.22
0.31
3.13%
Últ. Act.: Oct 26, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Ganancias:
Los beneficios de Q3 2026 mañana en mié oct 28th después del cierre del mercado
Conferencia telefónica:
Conferencia telefónica programada para mañana a las 8:30 a. m.
Haz clic para ver el webcast
Core Laboratories Financials
Core Laboratories (CLB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Top 3 Energy Stocks You'll Regret Missing In September
Oversold energy stocks may offer buying opportunities, with Baker Hughes, CNX Resources and Core Laboratories showing RSI readings below 30.
Avi Kapoor
PRO
Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 42.11 percent decrease over earnings of $0.19 per share from the
Benzinga Newsdesk
PRO
Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.330M Est
Core Laboratories (NYSE:CLB) is looking for Q3 GAAP EPS of $0.12-$0.20 vs $0.16 analyst estimate. sees sales of $128.500 million-$135.500 million vs $131.330 million analyst estimate.
Benzinga Newsdesk
PRO
Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.900M Est
Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.06-$0.12 vs $0.09 analyst estimate. sees sales of $123.000 million-$131.000 million vs $127.900 million analyst estimate.
Benzinga Newsdesk
PRO
Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.11 by 45.45 percent. This is a 57.14 percent decrease over earnings of $0.14 per share from
Benzinga Newsdesk
Earnings Scheduled For April 29, 2026
Benzinga Insights
